Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

3.4K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.4K
Nephrons01:10

Nephrons

3.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.5K
Overview of Exosomes01:36

Overview of Exosomes

2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

379
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
379
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

2.6K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.6K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

41
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Vesicles, Liposomes, and Hybrid Nanovesicles: Comparative Strategies for Targeted Cancer Therapy.

International journal of molecular sciences·2026
Same author

Engineered Red Blood Cell-Derived Extracellular Vesicles With Klotho Peptide Protect the Kidney From Fibrosis.

Journal of extracellular biology·2026
Same author

Diagnostic and Therapeutic Roles of Extracellular Vesicles in Chronic Kidney Disease: A Systematic Review.

Journal of extracellular vesicles·2026
Same author

Good Manufacturing Practice-Derived Human Liver Stem Cell Extracellular Vesicles Attenuate Liver Fibrosis In Vivo.

Cells·2026
Same author

Orange-Derived Extracellular Vesicles: Characterization and Therapeutic Applications in Normal and Diabetic Wound Healing in In Vivo Models.

Cells·2026
Same author

Updating MISEV: When, What, How, and Why?

Journal of extracellular vesicles·2026

Related Experiment Video

Updated: Sep 21, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

Extracellular vesicles in kidney disease.

Cristina Grange1, Benedetta Bussolati2

  • 1Department of Medical Sciences, University of Turin, Turin, Italy.

Nature Reviews. Nephrology
|May 31, 2022
PubMed
Summary

Extracellular vesicles (EVs) are key in cell communication and kidney health. EVs show potential for diagnosing kidney disease and may be used therapeutically for regeneration and drug delivery.

More Related Videos

A Modified Precipitation Method to Isolate Urinary Exosomes
05:05

A Modified Precipitation Method to Isolate Urinary Exosomes

Published on: January 16, 2015

17.7K
Setting a Successful Sorting for Extracellular Vesicle Isolation
08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.2K

Related Experiment Videos

Last Updated: Sep 21, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K
A Modified Precipitation Method to Isolate Urinary Exosomes
05:05

A Modified Precipitation Method to Isolate Urinary Exosomes

Published on: January 16, 2015

17.7K
Setting a Successful Sorting for Extracellular Vesicle Isolation
08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.2K

Area of Science:

  • Cell Biology
  • Nephrology
  • Biotechnology

Background:

  • Extracellular vesicles (EVs) are released by most cells and mediate intercellular communication.
  • EVs play critical roles in kidney physiology and pathology, influencing cell crosstalk and organ interactions.
  • Their molecular cargo reflects the originating cell's status, suggesting diagnostic potential.

Purpose of the Study:

  • To review the role of EVs in kidney function and disease.
  • To explore the diagnostic and prognostic potential of EVs in nephrology.
  • To discuss the therapeutic applications of EVs, including kidney regeneration and drug delivery.

Main Methods:

  • Literature review of studies on extracellular vesicles in kidney research.
  • Analysis of the molecular mechanisms of EV-mediated cell communication in the kidney.
  • Evaluation of preclinical data on EV-based therapeutic strategies for kidney diseases.

Main Results:

  • Urinary and circulating EVs mediate critical crosstalk in kidney health and disease.
  • EVs' molecular profiles offer potential biomarkers for kidney conditions.
  • Preclinical studies demonstrate EV capacity to promote kidney regeneration and reduce fibrosis.

Conclusions:

  • Extracellular vesicles are pivotal in kidney pathophysiology and hold significant promise for diagnostics.
  • EVs derived from stem cells are particularly promising for regenerative therapies in kidney disease.
  • Standardization and scalable production are crucial for the clinical translation of EV-based therapeutics.